CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Bains has stepped down from his role on the Biocon Board as an Independent Director with immediate effect
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
Subscribe To Our Newsletter & Stay Updated
